The Wuhan Institute of Virology operated reverse-genetics systems for constructing coronaviruses
3 events · 1 assessment · 1 decision
Structured (left atomic) and assessed verified
First pass on a newly onboarded claim: "The Wuhan Institute of Virology operated reverse-genetics systems for constructing coronaviruses." Judged the claim atomic — it is an uncontested capability fact, and the stop rule is contestedness, not logical primitiveness; no informed party in the COVID-origins discourse disputes that WIV used reverse-genetics/infectious-clone systems for coronaviruses. Decomposing into underlying molecular techniques would add settled scaffolding, so no subclaims were created. Verified the fact via primary/peer-reviewed sources authored largely by WIV itself: Hu et al. 2017 (PLoS Pathogens) explicitly reports constructing infectious BAC clones with the WIV1 backbone and 8 bat SARSr-CoV spike genes using a reverse-genetics technique developed for WIV1; corroborated by Zeng et al. 2016 (J. Virol.) and by WIV supplying the WIV1 spike plasmid to the Baric group for the 2015 PNAS chimera study. Assessed VERIFIED at 0.95 (slight discount only for the paraphrase "operated ... for constructing"). Set importance 0.3: consulted within the live origins debate but the fact itself is settled; the contested downstream inference to SARS-CoV-2 is a distinct claim and out of scope here.
Assessed Verified
verdict confidence 0.95
The Wuhan Institute of Virology did operate reverse-genetics systems for building coronaviruses, and this is well documented in the peer-reviewed literature its own scientists published. Most directly, a 2017 study in PLoS Pathogens by WIV researchers reports using a reverse-genetics technique they had developed for the bat SARS-related coronavirus WIV1 to construct a panel of infectious BAC clones carrying the WIV1 backbone and spike genes from eight different bat SARSr-CoVs. Earlier WIV work (including on the WIV1 strain isolated in 2013) and collaborations that supplied WIV coronavirus sequences and plasmids to other groups corroborate that such capability existed at the institute. This factual point is not in serious dispute among researchers across the spectrum of views on COVID-19's origin; the genuine controversy lies in a separate question — whether any such work bears on the emergence of SARS-CoV-2 — which this claim does not address.
Claim entered the graph